Skip to content

Augmedix, Inc.

CIK 0001769804

← back to feed
Revenue (TTM)
$47.54M
+45.0% YoY Q2 Aug 2024
Net Income (TTM)
−$24.39M
+21.6% YoY Q2 Aug 2024
EPS Diluted (TTM)
−$0.50
+32.3% YoY Q2 Aug 2024
Gross Margin
49.8%
Q2 Aug 2024
Operating Margin
-51.5%
Q2 Aug 2024
Net Margin
-51.3%
Q2 Aug 2024
Free Cash Flow (TTM)
−$25.27M
Q2 Aug 2024
Cash
$28.22M
Q2 Aug 2024
Total Debt
$21M
Q2 Aug 2024
Shares Outstanding
49.24M sh
Q2 Aug 2024

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings